- Research works
- 22 ▼ 49% vs 2013–17
- Citations
- 332 14.9 per fractional work
- Top-10% rate
- 29.3% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: CURE Childhood Cancer is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.4×. Every wedge is a field page.
Which keywords describe research at CURE Childhood Cancer?
By fractional works in all years, weighted toward what it does more of than the world: Health-related Quality of Life, Childhood Cancer Survivor Study, Pediatric Quality of Life Inventory, Cancer, Prognostic Factors, Acute Lymphoblastic Leukemia, Childhood Cancer and Genetic Mutations.
- Neuroblastoma
- Prognosis
- Kidney Organoids
- Genetic Mutations
- Acute Lymphoblastic Leukemia
- Cancer
- Childhood Cancer Survivor Study
- Health-related Quality of Life
- Pediatric Quality of Life Inventory
- Prognostic Factors
- Childhood Cancer
- Immunotherapy
- Nephrogenesis
- ALK
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Health-related Quality of Life4▲ 78×2 topics
- Childhood Cancer Survivor Study4▲ 375×1 topic
- Pediatric Quality of Life Inventory4▲ 375×1 topic
- Cancer2▲ 8.0×16 topics
- Prognostic Factors2▲ 21×6 topics
- Acute Lymphoblastic Leukemia2▲ 205×1 topic
- Childhood Cancer2▲ 205×1 topic
- Genetic Mutations1▲ 12×8 topics
- Immunotherapy1▲ 8.1×4 topics
- Kidney Organoids1▲ 165×1 topic
- Nephrogenesis1▲ 165×1 topic
- Prognosis1▲ 17×4 topics
- ALK1▲ 140×1 topic
- Neuroblastoma1▲ 140×1 topic
Which research topics does CURE Childhood Cancer publish most on?
By volume in 2022–2025: Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Child and Adolescent Health and BRCA gene mutations in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 1 works
- 2 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 3 Child and Adolescent Health General Health Professions 0 works
- 4 BRCA gene mutations in cancer Genetics 0 works
- 5 Emotional Intelligence and Performance Social Psychology 0 works
- 6 Cancer Risks and Factors Oncology 0 works
- 7 Family Support in Illness Sociology and Political Science 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Global Maternal and Child Health Pediatrics, Perinatology and Child Health 0 works
- 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CURE Childhood Cancer's research output changed?
Output in 2018–2022 was 49% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Atlanta
- Georgia Institute of Technology
- Emory University
- Georgia State University
- Centers for Disease Control and Prevention
- AID Atlanta
- Morehouse School of Medicine
- Children's Healthcare of Atlanta
- Emory University Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.